nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.12.2010 | Review Article

Laser Treatment of Dark Skin

An Updated Review

verfasst von: Sona Shah, Dr Tina S. Alster

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The growing diversification of the patient population coupled with the increasing demand for cosmetic laser rejuvenation has highlighted the need to develop cutaneous laser systems and establish treatment protocols for patients with a wide range of skin conditions and phototypes. Recent technologic advancements have provided viable treatment options to achieve clinical outcomes that were previously only attainable in patients with lighter skin tones. This review provides an updated discussion of the range of laser treatments available for pigmented skin and sets the stage for further advancements.

Pigment-specific laser technology with green, red, or near-infrared light targets a variety of pigmented lesions such as lentigines, ephelides, café-au-lait macules, and melanocytic nevi as well as tattoos and unwanted hair. Short-pulsed alexandrite, ruby, and neodymium:yttrium-aluminum-garnet (Nd:YAG) lasers are used for pigmented lesions and tattoos, whereas their longer pulse-width laser counterparts are used for laser-assisted hair removal. Vascular lesions and hypertrophic scars can be treated with a variety of vascular-specific lasers, but it is the pulsed dye laser (PDL) that has long been the gold standard treatment for these lesions due to its high specificity for hemoglobin and its ability to improve skin surface texture in children and adults.

Laser skin resurfacing techniques for photodamaged skin and atrophic scars have been optimized with fractional technology to produce excellent clinical outcomes and minimal complication risks. Radiofrequency and nonablative lasers are also used to provide skin tightening and collagen remodeling with virtually no postoperative recovery.

American Society for Aesthetic Plastic Surgery. Survey data 2008 [online]. Available from URL: (http://www.plasticsurgery.org/Media/PressReleases/CosmeticProceduresUpInAllEthnicGroupsExceptCaucasiansIn2008.html) [Accessed 2010 Feb]

American Society for Dermatologic Surgery. Procedure survey data 2007 [online]. Available from URL: (http://www.asds.net/TheAmericanSocietyforDermatologicSurgeryReleasesNewProcedureSurveyData.aspx [Accessed 2010 Feb]

2008 US Census Bureau. An older and more diverse nation by mid-century [online]. Available from URL: (http://www.census.gov/Press-Release/www/releases/archives/population/012496.html) [Accessed 2010 Feb]

Macedo O, Alster TS. Laser treatment of darker skin tones: a practical approach. Dermatol Ther 2000; 13: 114–26CrossRef

Alster TS, Tanzi EL. Laser surgery in dark skin. Skin Med 2003; 2: 80–5CrossRef

Tanzi EL, Alster TS. Cutaneous laser surgery in darker skin phototypes. Cutis 2004; 73: 21–30PubMed

Bhatt N, Alster TS. Laser surgery in dark skin. Dermatol Surg 2008; 34: 184–95PubMedCrossRef

Anderson RR. Laser-tissue interactions in dermatology. In: Arndt KA, Dover JS, Olbricht SM, editors. Lasers in cutaneous and aesthetic surgery. Philadelphia (PA): Lippincott-Raven, 1997: 28

Tanzi EL, Lupton JR, Alster TS. Review of lasers in dermatology: four decades of progress. J Am Acad Dermatol 2003; 49: 1–31PubMedCrossRef

10.

Tse Y, Levine VJ, McClain SA, et al. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet: a comparative study. J Dermatol Surg Oncol 1994; 20: 795–800PubMed

11.

Kono T, Manstein D, Chan HH, et al. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med 2006; 38: 94–7PubMedCrossRef

12.

Chan HHL, Kono T. The use of lasers and intense pulsed light sources for the treatment of pigmentary lesions. Skin Ther Lett 2004; 9: 5–7

13.

Sadighha A, Saatee S, Muhaghegh-Zahed G. Efficacy and adverse effects of Q switched ruby laser on solar lentigines: a prospective study of 91 patients with Fitzpatrick skin type II, III and IV. Dermatol Surg 2008; 34: 1465–8PubMedCrossRef

14.

Ueda S, Isoda M, Imayama S. Response of naevus of Ota to Q-switched ruby laser treatment according to lesion colour. Br J Dermatol 2000; 142: 77–83PubMedCrossRef

15.

Chan HH, Ying SY, Ho WS, et al. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755-nm alexandrite and Q-switched 1064-nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg 2000; 26: 919–22PubMedCrossRef

16.

Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg 1995; 21: 592–6PubMedCrossRef

17.

Kono T, Nozaki M, Chan HH, et al.Aretrospective study looking at the longterm complication of Q-switched ruby laser in the treatment of nevus of Ota. Lasers Surg Med 2001; 29: 156–9PubMedCrossRef

18.

Kunachak S, Leelaudomlipi P, Sirikulchayanonta V. Q-switched ruby laser therapy of acquired bilateral nevus of Ota-like macules. Dermatol Surg 1999; 15: 938–41CrossRef

19.

Lam AY, Wong DS, Lam LK, et al. A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg 2001; 27: 937–42PubMedCrossRef

20.

Kunachak S, Leelaudomlipi P. Q-switched Nd:YAG laser treatment for acquired bilateral nevus of Ota-like maculae: a long-term follow-up. Lasers Surg Med 2000; 26: 376–9PubMedCrossRef

21.

Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg 2000; 26: 477–80PubMedCrossRef

22.

Ee HL, Goh CL, Chan ES, et al. Treatment of acquired bilateral nevus ofOtalike macules (Hori’s nevus) with a combination of the 532-nm Q-switched Nd:YAG laser followed by the 1064-nm Q-switched Nd:YAG laser is more effective: prospective study. Dermatol Surg 2006; 32: 34–40PubMed

23.

Chan HH, Leung RS, Yng SY, et al. Recurrence of nevus of Ota after successful treatment with Q-switched lasers. Arch Dermatol 2000; 136: 1175–6PubMedCrossRef

24.

Park MJ, Tsao H, Tsao S. Acquired bilateral nevus of Ota-like macules (Hori nevus): etiologic and therapeutic considerations. J Am Acad Dermatol 2009; 6: 88–93CrossRef

25.

Salem A, Gamil H, Ramadan A, et al. Melasma: treatment evaluation. J Cosmet Laser Ther 2009; 11: 146–50PubMedCrossRef

26.

Lee HS, Won CH, Lee DH, et al. Treatment of melasma in Asian skin using fractional 1550-nmlaser: an open clinical study. Dermatol Surg 2009; 35: 1499–504PubMedCrossRef

27.

Kundu RV, Joshi SS, Suh KY, et al. Comparison of electrodesiccation and potassium titanyl-phosphate laser for treatment of dermatosis papulosa nigra. Dermatol Surg 2009; 35: 1079–83PubMedCrossRef

28.

Kilmer SL. Laser treatment of tattoos. In: Alster TS, Apfelberg DB, editors. Cosmetic laser surgery: a practitioner’s guide. 2nd ed. New York: Wiley- Liss, 1999: 289–303

29.

Alster TS. Q-switched alexandrite (755-nm) laser treatment of professional and amateur tattoos. J Am Acad Dermatol 1995; 33: 69–73PubMedCrossRef

30.

Grevelink JM, Duke D, van Leeuwen RL, et al. Laser treatment of tattoos in darkly pigmented patients: efficacy and side effects. J Am Acad Dermatol 1996; 34: 653–6PubMedCrossRef

31.

Jones A, Roddey P, Orengo I, et al. The Q-switched Nd:YAG laser effectively treats tattoos in darkly pigmented skin. Dermatol Surg 1996; 22: 999–1001PubMedCrossRef

32.

Chang SE, Choi JH, Moon KC, et al. Successful removal of traumatic tattoos in Asian skin with a Q-switched alexandrite laser. Dermatol Surg 1998; 24: 1308–11PubMedCrossRef

33.

Nanni CA, Alster TS. Complications of laser-assisted hair removal using Q-switched Nd:YAG, long-pulsed ruby, and long-pulsed alexandrite lasers. J Am Acad Dermatol 1999; 41: 165–71PubMedCrossRef

34.

Chana JS, Grobbelaar AO. The long-term results of ruby laser depilation in a consecutive series of 346 patients. Plast Reconstr Surg 2002; 110: 254–60PubMedCrossRef

35.

Lu SY, Lee CC, Wu YY. Hair removal by long-pulse alexandrite laser in Oriental patients. Ann Plast Surg 2001; 47: 404–11PubMedCrossRef

36.

Garcia C, Alamoudi H, Nakib M, et al. Alexandrite laser hair removal is safe for Fitzpatrick skin types IV-VI. Dermatol Surg 2006; 26: 130–4CrossRef

37.

Handrick C, Alster TS. Comparison of long-pulsed diode and long-pulsed alexandrite lasers for hair removal: a long-term clinical and histologic study. Dermatol Surg 2001; 27: 622–6PubMedCrossRef

38.

Chan HH, Ying SY, Ho WS, et al. An in vivo study comparing the efficacy and complications of diode laser and long-pulsed neodymium:yttriumaluminum- garnet (Nd:YAG) laser in hair removal among Chinese patients. Dermatol Surg 2001; 27: 950–4PubMedCrossRef

39.

Yamauchi PS, Kelly PA, Lask GP. Treatment of pseudofolliculitis barbae with the diode laser. J Cutan Laser Ther 1999; 1: 109–11PubMed

40.

Greppi I.Diode laser hair removal of the black patient. Lasers Surg Med 2001; 28: 150–5

41.

Alster TS, Bryan H, Williams CM. Long-pulsed Nd:YAG laser-assisted hair removal in pigmented skin. Arch Dermatol 2001; 137: 885–9PubMed

42.

Trelles MA, Urdiales F, Al-Zarouni M. Hair structures are effectively altered during 810nm diode laser hair epilation at low fluences. J Dermatol Treat 2009; 1: 1–4CrossRef

43.

Nanni CA, Alster TS. Laser-assisted hair removal: optimizing treatment parameters to improve clinical results. Arch Dermatol 1997; 133: 1546–9PubMedCrossRef

44.

Tanzi EL, Alster TS. Long-pulsed 1064-nm Nd:YAG laser-assisted hair removal in all skin types. Dermatol Surg 2004; 30: 13–7PubMedCrossRef

45.

Lanigan GW. Incidence of side effects after laser hair removal. J Am Acad Dermatol 2003; 49: 882–6PubMedCrossRef

46.

Ross EV, Crooke LM, Timko AL, et al. Treatment of pseudofolliculitis barbae in skin types IV, V, and VI with a long-pulsed neodymium: yttrium aluminum garnet laser. J Am Acad Dermatol 2002; 47: 263–70PubMedCrossRef

47.

Fournier N. Hair removal on dark-skinned patients with pneumatic skin flattening and a high energyNd-YAGlaser. J Cosmet Laser Ther 2008; 10: 210–2PubMedCrossRef

48.

Bewdewi AF. Hair removal with intense pulsed light.LasersMed Sci 2004; 19: 48–51

49.

Gold MH. Lasers and light sources for the removal of unwanted hair. Clin Dermatol 2007; 25: 443–53PubMedCrossRef

50.

Gold MH, Foster TD, Adair M, et al. The treatment of dark skin (types V and VI) with the intense pulsed light source for hair removal. Int J Cosmet Surg Aesthet Dermatol 2000; 2: 35–9CrossRef

51.

Weir VM, Woo TY. Photo-assisted epilation: review and personal observations. J Cutan Laser Ther 1999; 1: 135–43PubMed

52.

Breadon JY, Barnes CA. Comparison of adverse events of laser and light-assisted hair removal systems in skin types IV-VI. J Drugs Dermatol 2007; 6: 40–6PubMed

53.

Goh CL. Comparative study on a single treatment response to long pulse Nd:YAG lasers and intense pulse light therapy for hair removal on skin type IV to VI: is longer wavelengths lasers preferred over shorter wavelengths lights for assisted hair removal. J Dermatol Treat 2003; 14: 243–7CrossRef

54.

Sadick NS, Krespi Y. Hair removal for Fitzpatrick skin types V and VI using light and heat energy technology. J Drugs Dermatol 2006; 5: 597–9

55.

Alster TS, Tanzi EL. The effect of a novel, low-energy, pulsed-light device for home-use hair removal. Dermatol Surg 2009; 35: 483–9PubMedCrossRef

56.

Alster TS, Railan D. Laser treatment of vascular birthmarks. J Craniofac Surg 2006; 4: 720–3CrossRef

57.

Garden JM, Bakus AD. Clinical efficacy of the pulsed dye laser in the treatment of vascular lesions. J Dermatol Surg Oncol 1993; 19: 321–6PubMed

58.

Anderson RR, Parrish JA.Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981; 1: 263–76PubMedCrossRef

59.

Morelli JG, Tan OT, Garden J, et al. Tunable dye laser (577 nm) treatment of port wine stains. Lasers Surg Med 1986; 6: 94–9PubMedCrossRef

60.

Alster TS, Wilson F. Treatment of port-wine stains with the flashlamppumped pulsed dye laser: extended clinical experience in children and adults. Ann Plast Surg 1994; 32: 478–84PubMedCrossRef

61.

Sharma VK, Shandpur S. Efficacy of pulsed dye laser in facial port-wine stains in Indian patients. Dermatol Surg 2007; 33: 560–6PubMedCrossRef

62.

Asahina A, Watanabe T, Kishi A, et al. Evaluation of the treatment of portwine stains with the 595nm long pulsed dye laser: a large prospective study in adult Japanese patients. J Am Acad Dermatol 2006; 54: 487–93PubMedCrossRef

63.

Sommer S, Sheehan-Dare RA. Pulsed dye laser treatment of port-wine stains in pigmented skin. J Am Acad Dermatol 2000; 42: 667–71PubMed

64.

Ho WS, Chan HH, Ying SY, et al. Laser treatment of congenital facial portwine stains: long-term efficacy and complication in Chinese patients. Lasers Surg Med 2002; 30: 44–7PubMedCrossRef

65.

Chang CJ, Nelson JS. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage. Dermatol Surg 1999; 25: 767–72PubMedCrossRef

66.

Chiu CH, Chan HH, Ho WS, et al. Prospective study of pulsed dye laser in conjunction with cryogen spray cooling for treatment of port wine stains in Chinese patients. Dermatol Surg 2003; 29: 909–15PubMedCrossRef

67.

Weiss RA, Dover JS. Laser surgery of leg veins. Dermatol Clin 2002; 1: 19–36

68.

Dover JS, Arndt KA. New approaches to the treatment of vascular lesions. Lasers Surg Med 2000; 26: 158–63PubMedCrossRef

69.

Yang MU, Yaroslavsky AN, Farinelli WA, et al. Long-pulsed neodymium: yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol 2005; 52: 480–90PubMedCrossRef

70.

Alster TS, Tanzi EL. Combined 595nm and 1064nm laser irradiation of recalcitrant and hypertrophic port-wine stains in children and adults. Dermatol Surg 2009; 35: 914–9PubMedCrossRef

71.

Kauvar AN, Loud WW. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol 2000; 136: 1371–5PubMedCrossRef

72.

Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003; 4: 235–43PubMedCrossRef

73.

Alster TS, Zaulyanov-Scanlon L. Laser scar revision: a review.Dermatol Surg 2007; 33: 131–40PubMedCrossRef

74.

Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 1998; 102: 2190–5PubMedCrossRef

75.

Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585nm flashlamp-pumped pulsed dye laser. Lancet 1995; 345: 1198–200PubMedCrossRef

76.

Reiken SR, Wolfort SF, Berthiamume F, et al. Control of hypertrophic scar growth using selective photothermolysis. Lasers Surg Med 1997; 21: 7–12PubMedCrossRef

77.

Kuo YR, Jeng SR, Wang FS, et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta, expression of extracellular matrix expression. Lasers Surg Med 2004; 34: 104–8PubMedCrossRef

78.

Alster TS, Tanzi EL. Laser skin resurfacing: ablative and nonablative. In: Robinson J, Sengelman R, Siegal DM, et al. editors. Surgery of the skin. Philadelphia (PA): Elsevier, 2005: 611–24

79.

Alster TS. Cutaneous resurfacing with CO2 and erbium:YAG lasers: preoperative, intraoperative, and postoperative considerations. Plast Reconstr Surg 1999; 103: 619–32PubMedCrossRef

80.

Ho C, Nguyen Q, Lowe NJ, et al. Laser resurfacing in pigmented skin.Dermatol Surg 1995; 21: 1035–7PubMedCrossRef

81.

Kim JW, Lee JO. Skin resurfacing with laser in Asians. Aesth Plast Surg 1997; 21: 115–7CrossRef

82.

Ruiz-Espara J, Gomez JM, de la Torre OL, et al. Ultrapulse laser skin resurfacing in Hispanic patients: a prospective study of 36 individuals. Dermatol Surg 1998; 24: 59–62CrossRef

83.

Alster TS, Hirsch RJ. Single-pass CO2 laser skin resurfacing of light and dark skin: extended experience with 52 patients. J Cosmetic Laser Ther 2003; 5: 39–42CrossRef

84.

Tanzi EL, Alster TS. Complications of ablative and nonablative lasers and light sources. In:Gloster Jr HM, editor. Complications in cutaneous surgery. New York: Springer, 2008: 167–82CrossRef

85.

Munavalli GS, Weiss RA, Halder R. Photoaging and nonablative photorejuvenation in ethnic skin. Dermatol Surg 2005; 31: 1250–61PubMedCrossRef

86.

Alster TS, Lupton JR.Are all infrared lasers equally effective in skin rejuvenation. Semin Cutan Med Surg 2002; 21: 274–9PubMedCrossRef

87.

Hardaway CA, Ross EV. Non-ablative laser skin remodeling. Dermatol Clin 2002; 20: 97–111PubMed

88.

Alam M, Hsu T, Dover JS, et al. Nonablative laser and light treatments: histology and tissue effects: a review. Lasers Surg Med 2003; 33: 30–9PubMedCrossRef

89.

Fitzpatrick R, Geronemus R, Goldberg D, et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med 2003; 33: 232–4PubMedCrossRef

90.

Alster TS, Tanzi EL. Improvement of neck and cheek laxity with a non-ablative radiofrequency device: a lifting experience. Dermatol Surg 2004; 30: 503–7PubMedCrossRef

91.

Alster TS, Lupton JR. Nonablative cutaneous remodeling using radiofrequency devices. Clin Dermatol 2007; 25: 487–91PubMedCrossRef

92.

Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719–37PubMedCrossRef

93.

Manstein D, Herron GS, Sink RV, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426–38PubMedCrossRef

94.

Hantash BM, Bedi VP, Kapadia B, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39: 96–107PubMedCrossRef

95.

Wanner M, Tanzi EL, Alster TS. Fractional photothermolysis: treatment of facial and nonfacial cutaneous photodamage with a 1500-nm erbium-doped fiber laser. Dermatol Surg 2007; 33: 23–8PubMedCrossRef

96.

Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg 2007; 33: 295–9PubMedCrossRef

97.

Kono T, Chan HH, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med 2007; 39: 311–4PubMedCrossRef

98.

Lee HS, Lee JH, Ahn GY, et al. Fractional photothermolysis for the treatment of acne scars: a report of 27 Korean patients. J Dermatol Treat 2008; 19: 45–9CrossRef

99.

Hu S, Chen MC, Lee MC, et al. Fractional resurfacing for the treatment of atrophic facial acne scars in Asian skin. Dermatol Surg 2009; 35: 826–32PubMedCrossRef

100.

Taub AF. Fractionated delivery systems for difficult to treat clinical applications: acne scarring, melasma, atrophic scarring, striae distensae, and deep rhytides. J Drugs Dermatol 2007; 6: 1120–8PubMed

101.

Kim BJ, Lee DH, Kim MN, et al. Fractional photothermolysis for the treatment of striae distensae in Asian skin. Am J Clin Dermatol 2008; 9: 33–7PubMedCrossRef

102.

Tierney EP, Kouba DJ, Hanke CW. Review of fractional photothermolysis: treatment indications and efficacy. Dermatol Surg 2009; 35: 1445–61PubMedCrossRef

103.

Tanzi EL, Wanitphakdeedecha R, Alster TS. Fraxel laser indications and long-term follow-up. Aesth Surg J 2008; 28 (6): 1–4CrossRef

104.

Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acneiform scarring withCO2 ablative fractional resurfacing.Lasers Surg Med 2008; 40: 381–6PubMedCrossRef

105.

Waibel J, Beer K, Narurkar V, et al.Preliminary observations on fractional ablative resurfacing devices: clinical impressions. J Drugs Dermatol 2009; 8: 481–5PubMed

106.

Kim S, Cho KH. Clinical trial of dual treatment with an ablative fractional laser and a nonablative laser for the treatment of acne scars in Asian patients. Dermatol Surg 2009; 35: 1089–98PubMedCrossRef

107.

Cho SB, Lee SJ, Kang JM, et al. The efficacy and safety of 10 600-nm carbon dioxide fractional laser for acne scars in Asian patients. Dermatol Surg 2009; 35: 1955–61PubMedCrossRef

108.

Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2008; 34: 301–7PubMedCrossRef

109.

Chan HH, Manstein D, Yu CS, et al. The prevalence and risk factors of postinflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med 2007; 39: 381–5PubMedCrossRef

110.

Tan KL, Kurniawati C, Gold MH. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO₂ laser device. J Drugs Dermatol 2008; 7: 774–7PubMed

111.

Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010; 36: 299–306PubMedCrossRef

Titel: Laser Treatment of Dark Skin
An Updated Review
verfasst von: Sona Shah
Dr Tina S. Alster
Publikationsdatum: 01.12.2010
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 6/2010
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.2165/11538940-000000000-00000

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

16.04.2024 | Infektiologie | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Laser Treatment of Dark Skin

An Updated Review

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

A Case of Hematidrosis Successfully Treated with Propranolol

Characterization of the UVA Protection Provided by Avobenzone, Zinc Oxide, and Titanium Dioxide in Broad-Spectrum Sunscreen Products

Acne Keloidalis Nuchae

Chronic Pruritus in the Absence of Specific Skin Disease

Acknowledgment

An Overview of Novel Therapies for Acute Hereditary Angioedema

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie